Bio Path | BPTH - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Baxter International USD 2.15B 133M 2026-06
Bio Path 13.65M 3.37M 2022-09
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03